Synovics Pharmaceuticals Stock Net Income
| SYVC Stock | USD 0.0001 0.00 0.00% |
By evaluating key metrics such as revenue growth, profitability, cash flow trends, and balance sheet strength, investors can better assess Synovics Pharmaceuticals' long-term financial health and intrinsic value.
This module does not cover all equities due to inconsistencies in global equity categorizations. Continue to Equity Screeners to view more equity screening tools. Synovics Pharmaceuticals Company Net Income Analysis
Synovics Pharmaceuticals' Net income is the profit of a company for the reporting period, which is derived after taking revenues and gains and subtracting all expenses and losses. Net income is one of the most-watched numbers by money managers as well as individual investors.
Current Synovics Pharmaceuticals Net Income | (4.01 M) |
Most of Synovics Pharmaceuticals' fundamental indicators, such as Net Income, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Synovics Pharmaceuticals is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Because income is reported on the Income Statement of a company and is measured in dollars some investors prefer to use Profit Margin, which measures income as a percentage of sales.
| Competition |
Based on the recorded statements, Synovics Pharmaceuticals reported net income of (4.01 Million). This is much lower than that of the Pharmaceuticals sector and significantly lower than that of the Health Care industry. The net income for all United States stocks is notably higher than that of the company.
Synovics Net Income Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Synovics Pharmaceuticals' direct or indirect competition against its Net Income to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Synovics Pharmaceuticals could also be used in its relative valuation, which is a method of valuing Synovics Pharmaceuticals by comparing valuation metrics of similar companies.Synovics Pharmaceuticals is currently under evaluation in net income category among its peers.
Synovics Fundamentals
| Return On Equity | -3.14 | ||||
| Return On Asset | -0.13 | ||||
| Profit Margin | (0.26) % | ||||
| Operating Margin | (1.18) % | ||||
| Current Valuation | 894.82 K | ||||
| Shares Outstanding | 29.83 M | ||||
| Price To Sales | 0.03 X | ||||
| Revenue | 25.96 M | ||||
| Gross Profit | 4.47 M | ||||
| EBITDA | (3.64 M) | ||||
| Net Income | (4.01 M) | ||||
| Cash And Equivalents | 129.86 K | ||||
| Total Debt | 2.1 M | ||||
| Current Ratio | 0.27 X | ||||
| Book Value Per Share | (0.06) X | ||||
| Cash Flow From Operations | 3.86 M | ||||
| Number Of Employees | 155 | ||||
| Beta | 163.31 | ||||
| Market Capitalization | 542.86 K | ||||
| Total Asset | 22.35 M | ||||
| Retained Earnings | (78.65 M) | ||||
| Working Capital | (12.87 M) | ||||
| Current Asset | 4.68 M | ||||
| Current Liabilities | 17.55 M | ||||
| Net Asset | 22.35 M |
About Synovics Pharmaceuticals Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Synovics Pharmaceuticals's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Synovics Pharmaceuticals using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Synovics Pharmaceuticals based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.When determining whether Synovics Pharmaceuticals offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Synovics Pharmaceuticals' financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Synovics Pharmaceuticals Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Synovics Pharmaceuticals Stock:Check out Synovics Pharmaceuticals Piotroski F Score and Synovics Pharmaceuticals Altman Z Score analysis. For information on how to trade Synovics Stock refer to our How to Trade Synovics Stock guide.You can also try the Investing Opportunities module to build portfolios using our predefined set of ideas and optimize them against your investing preferences.
Is Pharmaceuticals space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Synovics Pharmaceuticals. If investors know Synovics will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Synovics Pharmaceuticals listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of Synovics Pharmaceuticals is measured differently than its book value, which is the value of Synovics that is recorded on the company's balance sheet. Investors also form their own opinion of Synovics Pharmaceuticals' value that differs from its market value or its book value, called intrinsic value, which is Synovics Pharmaceuticals' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Synovics Pharmaceuticals' market value can be influenced by many factors that don't directly affect Synovics Pharmaceuticals' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Synovics Pharmaceuticals' value and its price as these two are different measures arrived at by different means. Investors typically determine if Synovics Pharmaceuticals is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Synovics Pharmaceuticals' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.